Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
25.06
-0.32 (-1.26%)
At close: Mar 20, 2026, 4:00 PM EDT
24.80
-0.26 (-1.04%)
After-hours: Mar 20, 2026, 7:56 PM EDT
Alumis Market Cap
Alumis has a market cap or net worth of $3.19 billion as of March 20, 2026. Its market cap has increased by 1,048.78% in one year.
Market Cap
3.19B
Enterprise Value
2.92B
1-Year Change
1,048.78%
Ranking
Category
Stock Price
$25.06
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $3.19B, an increase of 253.43%. That is a compound annual growth rate of 107.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.19B | 212.85% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 3.46B |
| Structure Therapeutics | 3.44B |
| ADMA Biologics | 3.41B |
| NewAmsterdam Pharma Company | 3.33B |
| Spyre Therapeutics | 3.24B |
| Legend Biotech | 3.22B |
| Denali Therapeutics | 3.13B |
| Edgewise Therapeutics | 3.12B |